Answer Genomics, a hyper-personalized and data-driven health startup, secured a $500K pre-series A round of funding from Inflection Point Ventures. Through strategic hiring campaigns, the funds will be used to grow the pool of talent and promote Sales and marketing.
By sequencing 10,000 genomes over the course of the next 12 months, these investments will also allow Answer Genomics to keep breaking new ground in genomics and ultimately improve people’s well-being through personalised health insights. efforts.
Read also – [Funding alert] Bolt.Earth Secures $20 Mn Funding to Power the EV Ecosystem
Rahul Ranganathan, CEO, Answer Genomics, says, “The advent of AI is changing the landscape of healthcare. We now possess the technology capable of understanding the human body for the masterpiece that it is. Multi-omnic data collected over a course of time forms a picture of current and future health allowing accurate prognosis, early diagnosis, and precision treatment. We believe precision health would reduce the burden on our healthcare infrastructure by allowing for accurate predictions, remote interventions, and faster recoveries.”
In order to compile a database of genetic data, the company is obtaining samples from individuals with their permission. Over five million data points from a tiny quantity of blood are analysed.
Read also – [Funding alert] Mensa Brands Secures $40 Mn In Debt Funding From EvolutionX
Vikram Ramasubramanian, Partner, Inflection Point Ventures, says, “Research and development in healthcare has always been of critical importance, with Genomics being at the cutting edge. Data science lends itself very well to Genomics, allowing healthcare companies to provide deep insights, and bio hacks to improve one’s lifestyle quality. As an early mover, Answer Genomics not only addresses an individual’s need for better health, but also provides data for large organizations to create better products.”
About Answer Genomics
The mission of Answer Genomics, a data-driven precision health company, is to help people make educated decisions about their health by leveraging the power of multi-omics data.
Read also – Cordis Acquires Medtech Company MedAlliance
A healthcare company called Answer Genomics uses genome-based information to assist people in making decisions. In order to decode their physical and mental health, they go straight to the source—their DNA and genes.
